Is Entera Bio Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Entera Bio Ltd (ENTX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Entera Bio Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Entera Bio Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Entera Bio Ltd?

Muslim investors may consider investing in Entera Bio Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Entera Bio Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Entera Bio Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Entera Bio Ltd updated?

The Shariah compliance status of Entera Bio Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Entera Bio Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Entera Bio Ltd?

You can check the latest Shariah compliance status of Entera Bio Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ENTX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 19, 2026

Report Source: 2025 Annual Report

Entera Bio Ltd. Stock Analysis ENTX

United States Health Care Micro Cap Report: 2025 Annual

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. The firm developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.

Key Statistics of Entera Bio Ltd (ENTX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.23$1.32

Today's Open

$1.30

Volume

84.72K

P/E Ratio (TTM)

52 Week Range

$0.91$3.22

Market Cap

54.08M

Avg. Volume

208.41K

Dividend Yield

Financial Metrics & Statements of Entera Bio Ltd (ENTX)

FAQ's for Entera Bio Ltd (ENTX)

According to Musaffa’s Shariah screening methodology, Entera Bio Ltd (ENTX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.